outcomes of patients with cll infected by covid-19 between 2020 and 2022
Published 1 year ago • 515 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
2:18
tools to improve the outcomes of patients with cll affected by covid-19
-
3:32
cll and covid-19: patient outcomes
-
1:46
retrospective analysis of covid-19 infection in cll patients
-
5:21
the effect of covid-19 on cll patient experiences
-
2:55
clinical outcomes of patients with cll receiving long-term ibrutinib in the resonate-2 study
-
4:51
vaccine efficacy in patients with cll
-
1:27:57
new rules for btk inhibitors in cll
-
44:01
instent restenosis: approach and detailed cases with ivus/oct
-
12:46
fixed duration treatment strategies in cll
-
1:51
responses to covid-19 vaccination in patients with cll
-
1:36
the utility of mrd for predicting treatment outcomes in patients with cll
-
2:56
clinical presentation & outcomes of covid-19 following hct
-
4:45
covid-19 risk factors in patients with hematologic malignancies
-
1:43
long-term outcomes of the ifcg regimen for firstline treatment of patients with ighv-mutated cll
-
2:30
towards strategies to optimize outcomes in cll
-
1:48
the importance of evaluating qualitative outcomes of patients with cll on targeted therapy
-
1:19
outcomes of cll patients following treatment with a covalent btk and bcl2 inhibitor
-
2:19
long-term management of cll for improved outcomes
-
5:17
covid-19: treating cll patients
-
1:20
improving patient outcomes in ctcl: clinical collaboration and novel agents
-
0:56
analysis of outcomes of younger cll patients
-
1:18
involving the patient in treatment decisions for cll